CancerClock: A DNA Methylation Age Predictor to Identify and Characterize Aging Clock in Pan-Cancer.

Tongtong Zhu, Yue Gao, Junwei Wang, Xin Li, Shipeng Shang, Yanxia Wang, Shuang Guo, Hanxiao Zhou, Hongjia Liu, Dailin Sun, Hong Chen, Li Wang, Shangwei Ning
Author Information
  1. Tongtong Zhu: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  2. Yue Gao: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  3. Junwei Wang: Department of Respiratory Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  4. Xin Li: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  5. Shipeng Shang: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  6. Yanxia Wang: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  7. Shuang Guo: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  8. Hanxiao Zhou: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  9. Hongjia Liu: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  10. Dailin Sun: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  11. Hong Chen: Department of Respiratory Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  12. Li Wang: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  13. Shangwei Ning: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.

Abstract

Many biological indicators related to chronological age have been proposed. Recent studies found that epigenetic clock or DNA methylation age is highly correlated with chronological age. In particular, a significant difference between DNA methylation age (m-age) and chronological age was observed in cancers. However, the prediction and characterization of m-age in pan-cancer remains an explored area. In this study, 1,631 age-related methylation sites in normal tissues were discovered and analyzed. A comprehensive computational model named CancerClock was constructed to predict the m-age for normal samples based on methylation levels of the extracted methylation sites. LASSO linear regression model was used to screen and train the CancerClock model in normal tissues. The accuracy of CancerClock has proved to be 81%, and the correlation value between chronological age and m-age was 0.939 ( < 0.01). Next, CancerClock was used to evaluate the difference between m-age and chronological age for 33 cancer types from TCGA. There were significant differences between predicted m-age and chronological age in large number of cancer samples. These cancer samples were defined as "age-related cancer samples" and they have some differential methylation sites. The differences between predicted m-age and chronological age may contribute to cancer development. Some of these differential methylation sites were associated with cancer survival. CancerClock provided assistance in estimating the m-age in normal and cancer samples. The changes between m-age and chronological age may improve the diagnosis and prognosis of cancers.

Keywords

References

  1. Hum Mutat. 2013 Dec;34(12):1606-10 [PMID: 24106010]
  2. J Stat Softw. 2010;33(1):1-22 [PMID: 20808728]
  3. J Exp Clin Cancer Res. 2015 Sep 11;34:102 [PMID: 26362431]
  4. Int J Oncol. 2016 Jun;48(6):2497-507 [PMID: 27082735]
  5. Sci Rep. 2016 Mar 07;6:22722 [PMID: 26949191]
  6. Clin Epigenetics. 2015 Sep 04;7:92 [PMID: 26347357]
  7. J Gastrointest Oncol. 2015 Dec;6(6):605-12 [PMID: 26697191]
  8. Brief Bioinform. 2019 Oct 28;:null [PMID: 31665214]
  9. Ageing Res Rev. 2018 Aug;45:15-23 [PMID: 29698722]
  10. Epigenomics. 2017 Jun;9(6):849-862 [PMID: 28403629]
  11. Clin Epigenetics. 2016 Jun 03;8:64 [PMID: 27274774]
  12. Stat Modelling. 2015 Jun 1;15(3):256-278 [PMID: 26441487]
  13. Ann Behav Med. 2017 Apr;51(2):214-225 [PMID: 27752991]
  14. Cancers (Basel). 2015 May 22;7(2):908-29 [PMID: 26010605]
  15. Mol Cancer. 2017 Jan 19;16(1):16 [PMID: 28103885]
  16. Genome Biol. 2014 Feb 03;15(2):R24 [PMID: 24490752]
  17. Genome Biol. 2017 Apr 11;18(1):68 [PMID: 28399939]
  18. Mol Ther Nucleic Acids. 2018 Sep 7;12:518-529 [PMID: 30195788]
  19. J Cell Mol Med. 2019 Aug;23(8):5270-5281 [PMID: 31140730]
  20. J Transl Med. 2015 Jul 17;13:231 [PMID: 26183581]
  21. Int J Cancer. 2015 Oct 1;137(7):1739-48 [PMID: 25821117]
  22. Breast Cancer Res. 2017 Jul 10;19(1):81 [PMID: 28693600]
  23. Methods Inf Med. 2016 Oct 17;55(5):422-430 [PMID: 27626931]
  24. Cell. 2018 Apr 5;173(2):283-285 [PMID: 29625045]
  25. Curr Environ Health Rep. 2018 Sep;5(3):317-327 [PMID: 30047075]
  26. Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1883-1888 [PMID: 29432166]
  27. Nat Commun. 2014 Dec 08;5:5659 [PMID: 25482515]
  28. Oncotarget. 2016 Aug 30;7(35):56383-56394 [PMID: 27487139]
  29. Int J Legal Med. 2018 Jan;132(1):1-11 [PMID: 28725932]
  30. Nucleic Acids Res. 2019 Jan 8;47(D1):D766-D773 [PMID: 30357393]
  31. Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1720-1724 [PMID: 31375479]
  32. Forensic Sci Int Genet. 2016 Sep;24:33-43 [PMID: 27288716]
  33. World J Gastroenterol. 2016 Dec 21;22(47):10325-10340 [PMID: 28058013]
  34. Aging Dis. 2017 Oct 1;8(5):611-627 [PMID: 28966805]
  35. Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7 [PMID: 27141961]
  36. Brief Bioinform. 2019 Mar 25;20(2):598-608 [PMID: 29672663]
  37. J Natl Cancer Inst. 2019 Oct 1;111(10):1051-1058 [PMID: 30794318]
  38. Genome Biol. 2013;14(10):R115 [PMID: 24138928]
  39. Nucleic Acids Res. 2019 Jan 8;47(D1):D983-D988 [PMID: 30364969]
  40. Physiol Rev. 2008 Apr;88(2):557-79 [PMID: 18391173]
  41. Genome Biol. 2019 Oct 15;20(1):209 [PMID: 31610796]
  42. Cancers (Basel). 2019 Oct 09;11(10):null [PMID: 31600992]
  43. Nature. 2015 Jan 15;517(7534):321-6 [PMID: 25592537]

Word Cloud

Similar Articles

Cited By